Healthcare provider profile · identity verified

Craig Cunningham, M.D.

Family Practice · WICHITA, KS · NPI 1598113888

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	519	140
Levothyroxine Sodium	Levothyroxine Sodium	381	83
Omeprazole	Omeprazole	380	85
Amlodipine Besylate	Amlodipine Besylate	353	81
Lisinopril	Lisinopril	331	91
Gabapentin	Gabapentin	269	47
Potassium Chloride	Potassium Chloride	261	54
Tamsulosin Hcl	Tamsulosin Hcl	243	61
Metoprolol Succinate	Metoprolol Succinate	232	50
Furosemide	Furosemide	224	57
Losartan Potassium	Losartan Potassium	221	59
Allopurinol	Allopurinol	167	37
Metformin Hcl	Metformin Hcl	167	38
Warfarin Sodium	Warfarin Sodium	165	19
Simvastatin	Simvastatin	153	43
Rosuvastatin Calcium	Rosuvastatin Calcium	131	32
Metoprolol Tartrate	Metoprolol Tartrate	125	24
Hydrochlorothiazide	Hydrochlorothiazide	116	33
Eliquis	Apixaban	112	22
Ozempic	Semaglutide	111	19
Finasteride	Finasteride	108	18
Escitalopram Oxalate	Escitalopram Oxalate	106	27
Albuterol Sulfate Hfa	Albuterol Sulfate	105	32
Metformin Hcl Er	Metformin Hcl	103	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	96	41
Famotidine	Famotidine	88	14
Zolpidem Tartrate	Zolpidem Tartrate	88	19
Meloxicam	Meloxicam	87	20
Xarelto	Rivaroxaban	84	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	80	17
Sertraline Hcl	Sertraline Hcl	80	19
Trazodone Hcl	Trazodone Hcl	80	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	22
Cephalexin	Cephalexin	75	57
Azithromycin	Azithromycin	73	62
Pravastatin Sodium	Pravastatin Sodium	68	16
Benazepril Hcl	Benazepril Hcl	67	16
Carvedilol	Carvedilol	67	20
Lorazepam	Lorazepam	67	24
Montelukast Sodium	Montelukast Sodium	67	16
Tramadol Hcl	Tramadol Hcl	66	22
Clonazepam	Clonazepam	64	suppressed
Duloxetine Hcl	Duloxetine Hcl	64	12
Quetiapine Fumarate	Quetiapine Fumarate	61	suppressed
Clopidogrel	Clopidogrel Bisulfate	58	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	50
Alprazolam	Alprazolam	56	13
Amitriptyline Hcl	Amitriptyline Hcl	53	12
Fluticasone Propionate	Fluticasone Propionate	47	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	suppressed
Pregabalin	Pregabalin	47	suppressed
Citalopram Hbr	Citalopram Hydrobromide	46	14
Bumetanide	Bumetanide	45	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	41	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	suppressed
Prednisone	Prednisone	40	29
Carbidopa-Levodopa	Carbidopa/Levodopa	39	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	35
Chlorthalidone	Chlorthalidone	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Jantoven	Warfarin Sodium	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Glimepiride	Glimepiride	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Spironolactone	Spironolactone	30	11
Triamcinolone Acetonide	Triamcinolone Acetonide	30	16
Atenolol	Atenolol	29	suppressed
Lactulose	Lactulose	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Glipizide	Glipizide	27	suppressed
Naproxen	Naproxen	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Tresiba Flextouch U-100	Insulin Degludec	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	17
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Estradiol	Estradiol	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	11
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Risperidone	Risperidone	23	suppressed
Colchicine	Colchicine	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Gemfibrozil	Gemfibrozil	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Digoxin	Digoxin	19	suppressed
Sulfasalazine	Sulfasalazine	19	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	18	suppressed
Amoxicillin	Amoxicillin	17	14
Calcitriol	Calcitriol	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Mupirocin	Mupirocin	17	14
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Aripiprazole	Aripiprazole	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Topiramate	Topiramate	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	13
Flecainide Acetate	Flecainide Acetate	15	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Phenytoin	Phenytoin	14	suppressed
Ramipril	Ramipril	14	suppressed
Rebif	Interferon Beta-1a/Albumin	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	13	suppressed
Cefdinir	Cefdinir	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Levemir	Insulin Detemir	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nystatin	Nystatin	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error